(Q35527367)

8 August 2017

title

Conditional probability of survival in patients with newly diagnosed glioblastoma (English)

1 reference

8 August 2017

1 reference

Mei-Yin C Polley

1

1 reference

8 August 2017

Kathleen R Lamborn

2

1 reference

8 August 2017

Susan M Chang

3

1 reference

8 August 2017

Nicholas Butowski

4

1 reference

8 August 2017

Jennifer L Clarke

5

1 reference

8 August 2017

Michael Prados

6

1 reference

8 August 2017

language of work or name

English

0 references

publication date

3 October 2011

1 reference

Journal of Clinical Oncology

8 August 2017

published in

1 reference

8 August 2017

volume

29

1 reference

8 August 2017

issue

31

1 reference

8 August 2017

page(s)

4175-4180

1 reference

Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208537

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208537

The conditional probabilities of survival in patients with anaplastic astrocytoma or glioblastoma multiforme

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208537

The conditional probability of survival of patients with primary malignant brain tumors: surveillance, epidemiology, and end results (SEER) data

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208537

Analysis of survival by tumor response.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208537

A phase II study of concurrent temozolomide and cis-retinoic acid with radiation for adult patients with newly diagnosed supratentorial glioblastoma.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208537

Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208537

The conditional survival statistics for survivors with primary supratentorial astrocytic tumors.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208537

Analysis of survival by tumor response and other comparisons of time-to-event by outcome variables

26 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21969507

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1200/JCO.2010.32.4343

1 reference

8 August 2017

1 reference

8 August 2017

1 reference